Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.85 |
| ▸ | PPARG | P37231 | 7/20 | 0.85 |
| ▸ | PPARD | Q03181 | 7/20 | 0.85 |
| ▸ | PPARA | Q07869 | 7/20 | 0.85 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.85 |
| ▸ | TSHR | P16473 | 4/20 | 0.85 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.85 |
| ▸ | FABP4 | P15090 | 3/20 | 0.85 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.85 |
| ▸ | TLR2 | O60603 | 2/20 | 0.85 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.85 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.85 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.85 |
| ▸ | MEN1 | O00255 | 1/20 | 0.85 |
| ▸ | ESR1 | P03372 | 1/20 | 0.85 |
| ▸ | PDE4A | P27815 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6839108 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL19816485 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL7824955 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL1134717 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL25287634 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL22413040 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL23804131 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL23203393 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL1134681 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD | |
| SCHEMBL7051056 | 1.00 | KMT2A (1.00) | KMT2AMAPTGPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119724395-A | Oxidized fatty acid scale qualitative method based on non-targeted metabonomics | 中国科学院大连化学物理研究所 | 2025-03-28 | — | — | CN | disclosed |
| EP-2435552-B1 | SOLVENT, SOLUTION, CLEANING COMPOSITION AND METHODS | GFBIOCHEMICALS IP ASSETS B V (NL) | 2018-10-17 | — | — | EP | disclosed |
| US-9593093-B2 | Methods for the manufacture of acetals and ketals, and the acetals and ketals produced thereby | GFBIOCHEMICALS LIMITED (MT) | 2017-03-14 | — | — | US | disclosed |
| CN-102414308-B | Solvent, solution, Cleasing compositions and method | GF生化有限公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-101896474-B | Process for the preparation of ketals and acetals | Xikaidis Co.,Ltd. (US) | 2016-02-03 | — | — | CN | disclosed |
| EP-2601184-B1 | METHODS FOR THE MANUFACTURE OF KETALS | SEGETIS INC (US) | 2015-12-16 | — | — | EP | disclosed |
| US-20150291567-A1 | TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS | GFBIOCHEMICALS LIMITED (MT) | 2015-10-15 | — | — | US | disclosed |
| CN-104478844-A | Method of making ketals and acetals | SEGETIS INC | 2015-04-01 | — | — | CN | disclosed |
| US-20150080585-A1 | METHODS FOR THE MANUFACTURE OF ACETALS AND KETALS, AND THE ACETALS AND KETALS PRODUCED THEREBY | GFBIOCHEMICALS LIMITED (MT) | 2015-03-19 | — | — | US | disclosed |
| CN-101883773-B | Polyketal compounds, synthesis, and applications | SEGETIS INC | 2014-05-21 | — | — | CN | disclosed |
| CN-101896474-A | Process for the preparation of ketals and acetals | GETIS INC | 2010-11-24 | — | — | CN | disclosed |
| US-20100292491-A1 | Method of Making Ketals and Acetals | SEGETIS, INC. (US) | 2010-11-18 | — | — | US | disclosed |
| CN-101883773-A | Polyketal compounds, synthesis, and applications | SEGETIS INC | 2010-11-10 | — | — | CN | disclosed |
| CN-101802052-A | ketal compounds from polyols and oxocarboxylates | SEGETIS INC | 2010-08-11 | — | — | CN | disclosed |
| EP-2209770-A1 | METHOD OF MAKING KETALS AND ACETALS | Segetis, Inc. (US) | 2010-07-28 | — | — | EP | disclosed |
| EP-2185625-A1 | KETAL COMPOUNDS FROM POLYOLS AND OXOCARBOXYLATES | Segetis, Inc. (US) | 2010-05-19 | — | — | EP | disclosed |
| WO-2009146202-A2 | TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS | SEGETIS, INC. (US) | 2009-12-03 | — | — | WO | disclosed |
| WO-2009048874-A1 | METHOD OF MAKING KETALS AND ACETALS | SEGETIS, INC. (US) | 2009-04-16 | — | — | WO | disclosed |
| WO-2009032905-A1 | KETAL COMPOUNDS FROM POLYOLS AND OXOCARBOXYLATES | SEGETIS, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| US-5296539-A | Containing graft impact-resistant vinylaromatic copolymer, polyamide resin, polyolefin | ECP ENICHEM POLIMERI S.R.L. (IT) | 1994-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080585-A1 | METHODS FOR THE MANUFACTURE OF ACETALS AND KETALS, AND THE ACETALS AND KETALS PRODUCED THEREBY | PKLR, GK, PKM | KMT2A 855/4885MAPT 1859/4885GPR84 3996/4885 |
| US-20100292491-A1 | Method of Making Ketals and Acetals | KAT6B, KAT5, ADH1C | KMT2A 88/4885MAPT 4275/4885GPR84 4058/4885 |
| US-20150291567-A1 | TRANSKETALIZED COMPOSITIONS, SYNTHESIS, AND APPLICATIONS | TKT, KHK, KYAT3 | KMT2A 532/4885MAPT 2200/4885GPR84 4173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.